Another study revealed that HIF1A-As2 epigenetically activates MYC by attracting DHX9 to the MYC promoter, thereby promoting the transcription of MYC and its target genes in KRAS-driven non-small cell lung cancer 49. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.